Business Categories Reports Podcasts Events Awards Webinars
Contact My Account About
Member Exclusive

Swedish Biotech Start-Up Melt&Marble Raises €7.3 Million

Published December 9, 2025
Published December 9, 2025
Andrej Lišakov via Unsplash

The Series A funding marks a pivotal moment for Melt&Marble, signalling cross-sector validation of its technology platform and commercial strategy.WHO: Melt&Marble was founded in 2014 in Gothenburg, Sweden, as a precision fermentation platform that offers animal-free, tailored fat structures that unlock superior functionality, from texture and mouthfeel in food to enhanced skin feel and bioactivity in cosmetics. By engineering fats from the molecule up, the business can deliver cost-competitive, locally produced ingredients that meet both technical demands and sustainability goals.WHY: The new funding will take Melt&Marble from demo to market-ready, with its first ingredients set for commercial launch in personal care applications in 2026. IN THEIR OWN WORDS: “This investment marks a major milestone for Melt&Marble as we transition from R&D to commercialisation. With key scalability milestones already achieved and strategic partners onboard, we’re entering the market with the capabilities and confidence to deliver real impact. Our vision has always been to deliver more sustainable, high-performance ingredients, and this round brings us significantly closer to that goal,” said Anastasia Krivoruchko, CEO of Melt&Marble.Tobias Elmquist, Senior Investment Director at Industrifonden, commented, “Melt&Marble has achieved an impressive level of technical and commercial readiness for a company at this stage. Their ability to engineer functional fats through precision fermentation addresses a clear and growing demand across industries.

×

2 Article(s) Remaining

Subscribe today for full access